Global Canine Stem Cell Therapy Market By Product Type (Embryonic stem cells, Adult stem cells); By Treatment (Intra-articular, Intra-lesion, Intra-venous); By Application (Arthritis, Dysplasia, Tendonitis, Inflammatory diseases, Immune Mediated Diseases, Bone and Spinal Cord Injuries, Others); By End User (Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Global canine stem cell therapy market is growing at an estimated CAGR of 17.5% over the forecast period (2022 – 2030). Medical science has made tremendous progress over the last decade and this is also applicable to pets or animals. The procedure of obtaining stem cell which is non-invasive along with optimistic results has made canine stem cell therapy a go to solution for veterinary physicians. This type of stem cell therapy is extremely safe and this is driving the growth of the Global Canine Stem Cell Therapy.
The COVID-19 pandemic has dented the growth of the global canine stem cell therapy market. Due to lockdown curbs imposed to curtail the spread of the dreadful virus, the veterinary clinics and hospitals were unable to render treatment. Similar was the situation of those seeking this kind of cell therapy.
Product Type Outlook
On the basis of product type, the global canine stem cell therapy market has been divided into embryonic stem cells, and adult stem cells. The embryonic stem cells are the ones derived from the inner cell mass of a blastocyst, that too at a very early stage in terms of pre-implantation embryo. This type of stem cell therapy is preferred by majority of veterinarians and this is the reason why this segment dominates in terms of revenue generation.
Treatment
On the basis of treatment, the global canine stem cell therapy market has been segregated into intra-articular, intra-lesion, and intra-venous. The intra-articular segment makes majority of the money for this market. The intra-articular injection is a type of shot that is placed directly in the joints in order to relieve the pain and this is why it is being used extensively.
Global Canine Stem Cell Therapy Market Revenue & Forecast, (US$ Million), 2022 – 2030
Application
On the basis of application, the global canine stem cell therapy market has been bifurcated into start-ups, small and medium organizations, and large organizations. Considering the size of consumer-base and continuously increasing competition, the large organizations segment in the canine stem cell therapy market generates majority of revenue.
Category
Category-wise, the global canine stem cell therapy market is segmented into arthritis, dysplasia, tendonitis, inflammatory diseases, immune mediated diseases, bone and spinal cord injuries, and others. The arthritis is a major ailment that causes severe pain and stem cell therapy is an effective treatment for it. Several veterinary hospitals, veterinary clinics and veterinary research institutes are rapidly using canine stem cell therapy.
End User
The end user segment of the global canine stem cell therapy market has been divided into veterinary hospitals, veterinary clinics and veterinary research institutes. As this type of therapy is still under research, this is primary reason that veterinary research institutes make majority of money for this market.
Region Outlook
On the basis of region, the global canine stem cell therapy market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of North America dominates in terms of market share courtesy of presence of several veterinary research institutes in countries like the US and Canada.
Competitive Landscape
The report provides both, qualitative and quantitative research of global canine stem cell therapy market as well as provides comprehensive insights and development methods adopted by the key contenders. the report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global canine stem cell therapy market are listed below:
- Animacel
- ANIMAL CELL THERAPIES, INC
- Aratana Therapeutics
- Cell Therapy Sciences
- Gallant
- LiteCure, LLC
- Magellan Stem Cells
- Medrego LLC
- Stemcell Vet
- Vetbiologics
- VetNetwork, LLC
- VETSTEM BIOPHARMA
- VetStem Inc
- Other Market Participants
Global Canine Stem Cell Therapy Market
By Product
- Embryonic stem cells
- Adult stem cells
By Treatment
- Intra-articular
- Intra-lesion
- Intra-venous
By Application
- Arthritis
- Dysplasia
- Tendonitis
- Inflammatory diseases
- Immune Mediated Diseases
- Bone and Spinal Cord Injuries
- Others
By End User
- Veterinary Hospitals
- Veterinary Clinics
- Veterinary Research Institutes
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Canine Stem Cell Therapy Market
6. Market Synopsis:
Canine Stem Cell Therapy Market
7. Canine Stem Cell Therapy Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Canine Stem Cell Therapy Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Canine Stem Cell Therapy Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Canine Stem Cell Therapy Market
8. Global Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global
Canine Stem Cell Therapy Market Revenue (US$ Mn)
8.2. Global
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Product Type
8.2.1. Embryonic
stem cells
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2021
8.2.1.5.1.2. Market
Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2021
8.2.1.5.2.2. Market
Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2021
8.2.1.5.3.2. Market
Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2021
8.2.1.5.4.2. Market
Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2021
8.2.1.5.5.2. Market
Forecast, 2022 – 2030
8.2.2. Adult stem cells
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2021
8.2.2.5.1.2. Market
Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2021
8.2.2.5.2.2. Market
Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2021
8.2.2.5.3.2. Market
Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2021
8.2.2.5.4.2. Market
Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2021
8.2.2.5.5.2. Market
Forecast, 2022 – 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Product Type
9. Global Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
9.1. Overview
9.2. Global
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Treatment
9.2.1. Intra-articular
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2021
9.2.1.5.1.2. Market
Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2021
9.2.1.5.2.2. Market
Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2021
9.2.1.5.3.2. Market
Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2021
9.2.1.5.4.2. Market
Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2021
9.2.1.5.5.2. Market
Forecast, 2022 – 2030
9.2.2. Intra-lesion
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2021
9.2.2.5.1.2. Market
Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2021
9.2.2.5.2.2. Market
Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2021
9.2.2.5.3.2. Market
Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2021
9.2.2.5.4.2. Market
Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2021
9.2.2.5.5.2. Market
Forecast, 2022 – 2030
9.2.3. Intra-venous
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2021
9.2.3.5.1.2. Market
Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2021
9.2.3.5.2.2. Market
Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2021
9.2.3.5.3.2. Market
Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2021
9.2.3.5.4.2. Market
Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2021
9.2.3.5.5.2. Market
Forecast, 2022 – 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Treatment
10. Global Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
10.2.1. Arthritis
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2021
10.2.1.5.1.2. Market
Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2021
10.2.1.5.2.2. Market
Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2021
10.2.1.5.3.2. Market
Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2021
10.2.1.5.4.2. Market
Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2021
10.2.1.5.5.2. Market
Forecast, 2022 – 2030
10.2.2. Dysplasia
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2021
10.2.2.5.1.2. Market
Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2021
10.2.2.5.2.2. Market
Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2021
10.2.2.5.3.2. Market
Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2021
10.2.2.5.4.2. Market
Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2021
10.2.2.5.5.2. Market
Forecast, 2022 – 2030
10.2.3. Tendonitis
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2021
10.2.3.5.1.2. Market
Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2021
10.2.3.5.2.2. Market
Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2021
10.2.3.5.3.2. Market
Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2021
10.2.3.5.4.2. Market
Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2021
10.2.3.5.5.2. Market
Forecast, 2022 – 2030
10.2.4. Inflammatory
diseases
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2021
10.2.4.5.1.2. Market
Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2021
10.2.4.5.2.2. Market
Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2021
10.2.4.5.3.2. Market
Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2021
10.2.4.5.4.2. Market
Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2021
10.2.4.5.5.2. Market
Forecast, 2022 – 2030
10.2.5. Immune
Mediated Diseases
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2021
10.2.5.3. Market Forecast, 2022 – 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2021
10.2.5.5.1.2. Market
Forecast, 2022 – 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2021
10.2.5.5.2.2. Market
Forecast, 2022 – 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2021
10.2.5.5.3.2. Market
Forecast, 2022 – 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2021
10.2.5.5.4.2. Market
Forecast, 2022 – 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2021
10.2.5.5.5.2. Market
Forecast, 2022 – 2030
10.2.6. Bone
and Spinal Cord Injuries
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2021
10.2.6.3. Market Forecast, 2022 – 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market
Estimation, 2021
10.2.6.5.1.2. Market
Forecast, 2022 – 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2021
10.2.6.5.2.2. Market
Forecast, 2022 – 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market
Estimation, 2021
10.2.6.5.3.2. Market
Forecast, 2022 – 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market
Estimation, 2021
10.2.6.5.4.2. Market
Forecast, 2022 – 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market
Estimation, 2021
10.2.6.5.5.2. Market
Forecast, 2022 – 2030
10.2.7. Others
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2021
10.2.7.3. Market Forecast, 2022 – 2030
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market
Estimation, 2021
10.2.7.5.1.2. Market
Forecast, 2022 – 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2021
10.2.7.5.2.2. Market
Forecast, 2022 – 2030
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market
Estimation, 2021
10.2.7.5.3.2. Market
Forecast, 2022 – 2030
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market
Estimation, 2021
10.2.7.5.4.2. Market
Forecast, 2022 – 2030
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market
Estimation, 2021
10.2.7.5.5.2. Market
Forecast, 2022 – 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Veterinary
Hospitals
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2021
11.2.1.5.1.2. Market
Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2021
11.2.1.5.2.2. Market
Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2021
11.2.1.5.3.2. Market
Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2021
11.2.1.5.4.2. Market
Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2021
11.2.1.5.5.2. Market
Forecast, 2022 – 2030
11.2.2. Veterinary
Clinics
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2021
11.2.2.5.1.2. Market
Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2021
11.2.2.5.2.2. Market
Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2021
11.2.2.5.3.2. Market
Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2021
11.2.2.5.4.2. Market
Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2021
11.2.2.5.5.2. Market
Forecast, 2022 – 2030
11.2.3. Veterinary
Research Institutes
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2021
11.2.3.5.1.2. Market
Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2021
11.2.3.5.2.2. Market
Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2021
11.2.3.5.3.2. Market
Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2021
11.2.3.5.4.2. Market
Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2021
11.2.3.5.5.2. Market
Forecast, 2022 – 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End
User
12. North America Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North
America Canine Stem Cell Therapy Market Revenue (US$ Mn)
12.2. North
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Product Type
12.2.1. Embryonic
stem cells
12.2.2. Adult stem cells
12.3. North
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Treatment
12.3.1. Intra-articular
12.3.2. Intra-lesion
12.3.3. Intra-venous
12.4. North
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
12.4.1. Arthritis
12.4.2. Dysplasia
12.4.3. Tendonitis
12.4.4. Inflammatory
diseases
12.4.5. Immune
Mediated Diseases
12.4.6. Bone
and Spinal Cord Injuries
12.4.7. Others
12.5. North
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By End
User
12.5.1. Veterinary
Hospitals
12.5.2. Veterinary
Clinics
12.5.3. Veterinary
Research Institutes
12.6. North
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.6.1.1.1. Embryonic stem cells
12.6.1.1.2. Adult stem cells
12.6.1.2. U.S Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
12.6.1.2.1. Intra-articular
12.6.1.2.2. Intra-lesion
12.6.1.2.3. Intra-venous
12.6.1.3. U.S Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.1.3.1. Arthritis
12.6.1.3.2. Dysplasia
12.6.1.3.3. Tendonitis
12.6.1.3.4. Inflammatory diseases
12.6.1.3.5. Immune Mediated Diseases
12.6.1.3.6. Bone and Spinal Cord Injuries
12.6.1.3.7. Others
12.6.1.4. U.S Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.1.4.1. Veterinary Hospitals
12.6.1.4.2. Veterinary Clinics
12.6.1.4.3. Veterinary Research Institutes
12.6.2. Canada
12.6.2.1. Canada Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.6.2.1.1. Embryonic stem cells
12.6.2.1.2. Adult stem cells
12.6.2.2. Canada Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
12.6.2.2.1. Intra-articular
12.6.2.2.2. Intra-lesion
12.6.2.2.3. Intra-venous
12.6.2.3. Canada Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.2.3.1. Arthritis
12.6.2.3.2. Dysplasia
12.6.2.3.3. Tendonitis
12.6.2.3.4. Inflammatory diseases
12.6.2.3.5. Immune Mediated Diseases
12.6.2.3.6. Bone and Spinal Cord Injuries
12.6.2.3.7. Others
12.6.2.4. Canada Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.2.4.1. Veterinary Hospitals
12.6.2.4.2. Veterinary Clinics
12.6.2.4.3. Veterinary Research Institutes
12.6.3. Mexico
12.6.3.1. Mexico Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
12.6.3.1.1. Embryonic stem cells
12.6.3.1.2. Adult stem cells
12.6.3.2. Mexico Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
12.6.3.2.1. Intra-articular
12.6.3.2.2. Intra-lesion
12.6.3.2.3. Intra-venous
12.6.3.3. Mexico Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
12.6.3.3.1. Arthritis
12.6.3.3.2. Dysplasia
12.6.3.3.3. Tendonitis
12.6.3.3.4. Inflammatory diseases
12.6.3.3.5. Immune Mediated Diseases
12.6.3.3.6. Bone and Spinal Cord Injuries
12.6.3.3.7. Others
12.6.3.4. Mexico Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1. Veterinary Hospitals
12.6.3.4.2. Veterinary Clinics
12.6.3.4.3. Veterinary Research Institutes
12.6.4. Rest of
North America
12.6.4.1. Rest of North America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Product Type
12.6.4.1.1. Embryonic stem cells
12.6.4.1.2. Adult stem cells
12.6.4.2. Rest of North America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Treatment
12.6.4.2.1. Intra-articular
12.6.4.2.2. Intra-lesion
12.6.4.2.3. Intra-venous
12.6.4.3. Rest of North America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
12.6.4.3.1. Arthritis
12.6.4.3.2. Dysplasia
12.6.4.3.3. Tendonitis
12.6.4.3.4. Inflammatory diseases
12.6.4.3.5. Immune Mediated Diseases
12.6.4.3.6. Bone and Spinal Cord Injuries
12.6.4.3.7. Others
12.6.4.4. Rest of North America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
12.6.4.4.1. Veterinary Hospitals
12.6.4.4.2. Veterinary Clinics
12.6.4.4.3. Veterinary Research Institutes
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Product Type
12.7.3. By
Treatment
12.7.4. By
Application
12.7.5. By End
User
13. Europe Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe
Canine Stem Cell Therapy Market Revenue (US$ Mn)
13.2. Europe Canine
Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Product Type
13.2.1. Embryonic
stem cells
13.2.2. Adult stem cells
13.3. Europe
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Treatment
13.3.1. Intra-articular
13.3.2. Intra-lesion
13.3.3. Intra-venous
13.4. Europe Canine
Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Arthritis
13.4.2. Dysplasia
13.4.3. Tendonitis
13.4.4. Inflammatory
diseases
13.4.5. Immune
Mediated Diseases
13.4.6. Bone
and Spinal Cord Injuries
13.4.7. Others
13.5. Europe
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By End User
13.5.1. Veterinary
Hospitals
13.5.2. Veterinary
Clinics
13.5.3. Veterinary
Research Institutes
13.6. Europe
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.1.1.1. Embryonic stem cells
13.6.1.1.2. Adult stem cells
13.6.1.2. France Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.1.2.1. Intra-articular
13.6.1.2.2. Intra-lesion
13.6.1.2.3. Intra-venous
13.6.1.3. France Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.1.3.1. Arthritis
13.6.1.3.2. Dysplasia
13.6.1.3.3. Tendonitis
13.6.1.3.4. Inflammatory diseases
13.6.1.3.5. Immune Mediated Diseases
13.6.1.3.6. Bone and Spinal Cord Injuries
13.6.1.3.7. Others
13.6.1.4. France Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1. Veterinary Hospitals
13.6.1.4.2. Veterinary Clinics
13.6.1.4.3. Veterinary Research Institutes
13.6.2. The UK
13.6.2.1. The UK Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.2.1.1. Embryonic stem cells
13.6.2.1.2. Adult stem cells
13.6.2.2. The UK Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.2.2.1. Intra-articular
13.6.2.2.2. Intra-lesion
13.6.2.2.3. Intra-venous
13.6.2.3. The UK Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.2.3.1. Arthritis
13.6.2.3.2. Dysplasia
13.6.2.3.3. Tendonitis
13.6.2.3.4. Inflammatory diseases
13.6.2.3.5. Immune Mediated Diseases
13.6.2.3.6. Bone and Spinal Cord Injuries
13.6.2.3.7. Others
13.6.2.4. The UK Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.2.4.1. Veterinary Hospitals
13.6.2.4.2. Veterinary Clinics
13.6.2.4.3. Veterinary Research Institutes
13.6.3. Spain
13.6.3.1. Spain Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.3.1.1. Embryonic stem cells
13.6.3.1.2. Adult stem cells
13.6.3.2. Spain Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.3.2.1. Intra-articular
13.6.3.2.2. Intra-lesion
13.6.3.2.3. Intra-venous
13.6.3.3. Spain Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.3.3.1. Arthritis
13.6.3.3.2. Dysplasia
13.6.3.3.3. Tendonitis
13.6.3.3.4. Inflammatory diseases
13.6.3.3.5. Immune Mediated Diseases
13.6.3.3.6. Bone and Spinal Cord Injuries
13.6.3.3.7. Others
13.6.3.4. Spain Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.3.4.1. Veterinary Hospitals
13.6.3.4.2. Veterinary Clinics
13.6.3.4.3. Veterinary Research Institutes
13.6.4. Germany
13.6.4.1. Germany Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
13.6.4.1.1. Embryonic stem cells
13.6.4.1.2. Adult stem cells
13.6.4.2. Germany Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.4.2.1. Intra-articular
13.6.4.2.2. Intra-lesion
13.6.4.2.3. Intra-venous
13.6.4.3. Germany Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.4.3.1. Arthritis
13.6.4.3.2. Dysplasia
13.6.4.3.3. Tendonitis
13.6.4.3.4. Inflammatory diseases
13.6.4.3.5. Immune Mediated Diseases
13.6.4.3.6. Bone and Spinal Cord Injuries
13.6.4.3.7. Others
13.6.4.4. Germany Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.4.4.1. Veterinary Hospitals
13.6.4.4.2. Veterinary Clinics
13.6.4.4.3. Veterinary Research Institutes
13.6.5. Italy
13.6.5.1. Italy Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By Product Type
13.6.5.1.1. Embryonic stem cells
13.6.5.1.2. Adult stem cells
13.6.5.2. Italy Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
13.6.5.2.1. Intra-articular
13.6.5.2.2. Intra-lesion
13.6.5.2.3. Intra-venous
13.6.5.3. Italy Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.5.3.1. Arthritis
13.6.5.3.2. Dysplasia
13.6.5.3.3. Tendonitis
13.6.5.3.4. Inflammatory diseases
13.6.5.3.5. Immune Mediated Diseases
13.6.5.3.6. Bone and Spinal Cord Injuries
13.6.5.3.7. Others
13.6.5.4. Italy Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.5.4.1. Veterinary Hospitals
13.6.5.4.2. Veterinary Clinics
13.6.5.4.3. Veterinary Research Institutes
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Product Type
13.6.6.1.1. Embryonic stem cells
13.6.6.1.2. Adult stem cells
13.6.6.2. Nordic Countries Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Treatment
13.6.6.2.1. Intra-articular
13.6.6.2.2. Intra-lesion
13.6.6.2.3. Intra-venous
13.6.6.3. Nordic Countries Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.6.3.1. Arthritis
13.6.6.3.2. Dysplasia
13.6.6.3.3. Tendonitis
13.6.6.3.4. Inflammatory diseases
13.6.6.3.5. Immune Mediated Diseases
13.6.6.3.6. Bone and Spinal Cord Injuries
13.6.6.3.7. Others
13.6.6.4. Nordic Countries Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.6.4.1. Veterinary Hospitals
13.6.6.4.2. Veterinary Clinics
13.6.6.4.3. Veterinary Research Institutes
13.6.6.5. Nordic Countries Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Product Type
13.6.7.1.1. Embryonic stem cells
13.6.7.1.2. Adult stem cells
13.6.7.2. Benelux Union Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Treatment
13.6.7.2.1. Intra-articular
13.6.7.2.2. Intra-lesion
13.6.7.2.3. Intra-venous
13.6.7.3. Benelux Union Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
13.6.7.3.1. Arthritis
13.6.7.3.2. Dysplasia
13.6.7.3.3. Tendonitis
13.6.7.3.4. Inflammatory diseases
13.6.7.3.5. Immune Mediated Diseases
13.6.7.3.6. Bone and Spinal Cord Injuries
13.6.7.3.7. Others
13.6.7.4. Benelux Union Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.7.4.1. Veterinary Hospitals
13.6.7.4.2. Veterinary Clinics
13.6.7.4.3. Veterinary Research Institutes
13.6.7.5. Benelux Union Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Product Type
13.6.8.1.1. Embryonic stem cells
13.6.8.1.2. Adult stem cells
13.6.8.2. Rest of Europe Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Treatment
13.6.8.2.1. Intra-articular
13.6.8.2.2. Intra-lesion
13.6.8.2.3. Intra-venous
13.6.8.3. Rest of Europe Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Application
13.6.8.3.1. Arthritis
13.6.8.3.2. Dysplasia
13.6.8.3.3. Tendonitis
13.6.8.3.4. Inflammatory diseases
13.6.8.3.5. Immune Mediated Diseases
13.6.8.3.6. Bone and Spinal Cord Injuries
13.6.8.3.7. Others
13.6.8.4. Rest of Europe Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By End User
13.6.8.4.1. Veterinary Hospitals
13.6.8.4.2. Veterinary Clinics
13.6.8.4.3. Veterinary Research Institutes
13.7. Key
Segment for Channeling Investments
13.7.1. By
Country
13.7.2. By
Product Type
13.7.3. By
Treatment
13.7.4. By
Application
13.7.5. By End
User
14. Asia Pacific Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia
Pacific Canine Stem Cell Therapy Market Revenue (US$ Mn)
14.2. Asia Pacific
Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By Product Type
14.2.1. Embryonic
stem cells
14.2.2. Adult stem cells
14.3. Asia
Pacific Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Treatment
14.3.1. Intra-articular
14.3.2. Intra-lesion
14.3.3. Intra-venous
14.4. Asia
Pacific Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1. Arthritis
14.4.2. Dysplasia
14.4.3. Tendonitis
14.4.4. Inflammatory
diseases
14.4.5. Immune
Mediated Diseases
14.4.6. Bone
and Spinal Cord Injuries
14.4.7. Others
14.5. Asia
Pacific Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By End
User
14.5.1. Veterinary
Hospitals
14.5.2. Veterinary
Clinics
14.5.3. Veterinary
Research Institutes
14.6. Asia
Pacific Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.1.1.1. Embryonic stem cells
14.6.1.1.2. Adult stem cells
14.6.1.2. China Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.1.2.1. Intra-articular
14.6.1.2.2. Intra-lesion
14.6.1.2.3. Intra-venous
14.6.1.3. China Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.1.3.1. Arthritis
14.6.1.3.2. Dysplasia
14.6.1.3.3. Tendonitis
14.6.1.3.4. Inflammatory diseases
14.6.1.3.5. Immune Mediated Diseases
14.6.1.3.6. Bone and Spinal Cord Injuries
14.6.1.3.7. Others
14.6.1.4. China Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.1.4.1. Veterinary Hospitals
14.6.1.4.2. Veterinary Clinics
14.6.1.4.3. Veterinary Research Institutes
14.6.2. Japan
14.6.2.1. Japan Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.2.1.1. Embryonic stem cells
14.6.2.1.2. Adult stem cells
14.6.2.2. Japan Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.2.2.1. Intra-articular
14.6.2.2.2. Intra-lesion
14.6.2.2.3. Intra-venous
14.6.2.3. Japan Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.2.3.1. Arthritis
14.6.2.3.2. Dysplasia
14.6.2.3.3. Tendonitis
14.6.2.3.4. Inflammatory diseases
14.6.2.3.5. Immune Mediated Diseases
14.6.2.3.6. Bone and Spinal Cord Injuries
14.6.2.3.7. Others
14.6.2.4. Japan Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.2.4.1. Veterinary Hospitals
14.6.2.4.2. Veterinary Clinics
14.6.2.4.3. Veterinary Research Institutes
14.6.3. India
14.6.3.1. India Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.3.1.1. Embryonic stem cells
14.6.3.1.2. Adult stem cells
14.6.3.2. India Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.3.2.1. Intra-articular
14.6.3.2.2. Intra-lesion
14.6.3.2.3. Intra-venous
14.6.3.3. India Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.3.3.1. Arthritis
14.6.3.3.2. Dysplasia
14.6.3.3.3. Tendonitis
14.6.3.3.4. Inflammatory diseases
14.6.3.3.5. Immune Mediated Diseases
14.6.3.3.6. Bone and Spinal Cord Injuries
14.6.3.3.7. Others
14.6.3.4. India Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.3.4.1. Veterinary Hospitals
14.6.3.4.2. Veterinary Clinics
14.6.3.4.3. Veterinary Research Institutes
14.6.4. New
Zealand
14.6.4.1. New Zealand Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.6.4.1.1. Embryonic stem cells
14.6.4.1.2. Adult stem cells
14.6.4.2. New Zealand Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Treatment
14.6.4.2.1. Intra-articular
14.6.4.2.2. Intra-lesion
14.6.4.2.3. Intra-venous
14.6.4.3. New Zealand Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.4.3.1. Arthritis
14.6.4.3.2. Dysplasia
14.6.4.3.3. Tendonitis
14.6.4.3.4. Inflammatory diseases
14.6.4.3.5. Immune Mediated Diseases
14.6.4.3.6. Bone and Spinal Cord Injuries
14.6.4.3.7. Others
14.6.4.4. New Zealand Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.4.4.1. Veterinary Hospitals
14.6.4.4.2. Veterinary Clinics
14.6.4.4.3. Veterinary Research Institutes
14.6.5. Australia
14.6.5.1. Australia Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
14.6.5.1.1. Embryonic stem cells
14.6.5.1.2. Adult stem cells
14.6.5.2. Australia Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
14.6.5.2.1. Intra-articular
14.6.5.2.2. Intra-lesion
14.6.5.2.3. Intra-venous
14.6.5.3. Australia Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.3.1. Arthritis
14.6.5.3.2. Dysplasia
14.6.5.3.3. Tendonitis
14.6.5.3.4. Inflammatory diseases
14.6.5.3.5. Immune Mediated Diseases
14.6.5.3.6. Bone and Spinal Cord Injuries
14.6.5.3.7. Others
14.6.5.4. Australia Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.5.4.1. Veterinary Hospitals
14.6.5.4.2. Veterinary Clinics
14.6.5.4.3. Veterinary Research Institutes
14.6.6. South
Korea
14.6.6.1. South Korea Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Product Type
14.6.6.1.1. Embryonic stem cells
14.6.6.1.2. Adult stem cells
14.6.6.2. South Korea Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Treatment
14.6.6.2.1. Intra-articular
14.6.6.2.2. Intra-lesion
14.6.6.2.3. Intra-venous
14.6.6.3. South Korea Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.6.3.1. Arthritis
14.6.6.3.2. Dysplasia
14.6.6.3.3. Tendonitis
14.6.6.3.4. Inflammatory diseases
14.6.6.3.5. Immune Mediated Diseases
14.6.6.3.6. Bone and Spinal Cord Injuries
14.6.6.3.7. Others
14.6.6.4. South Korea Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.6.4.1. Veterinary Hospitals
14.6.6.4.2. Veterinary Clinics
14.6.6.4.3. Veterinary Research Institutes
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Product Type
14.6.7.1.1. Embryonic stem cells
14.6.7.1.2. Adult stem cells
14.6.7.2. Southeast Asia Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Treatment
14.6.7.2.1. Intra-articular
14.6.7.2.2. Intra-lesion
14.6.7.2.3. Intra-venous
14.6.7.3. Southeast Asia Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Application
14.6.7.3.1. Arthritis
14.6.7.3.2. Dysplasia
14.6.7.3.3. Tendonitis
14.6.7.3.4. Inflammatory diseases
14.6.7.3.5. Immune Mediated Diseases
14.6.7.3.6. Bone and Spinal Cord Injuries
14.6.7.3.7. Others
14.6.7.4. Southeast Asia Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By End User
14.6.7.4.1. Veterinary Hospitals
14.6.7.4.2. Veterinary Clinics
14.6.7.4.3. Veterinary Research Institutes
14.6.7.5. Southeast Asia Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Product Type
14.6.8.1.1. Embryonic stem cells
14.6.8.1.2. Adult stem cells
14.6.8.2. Rest of Asia Pacific Canine Stem Cell Therapy Market Revenue (US$
Mn) and Forecasts, By Treatment
14.6.8.2.1. Intra-articular
14.6.8.2.2. Intra-lesion
14.6.8.2.3. Intra-venous
14.6.8.3. Rest of Asia Pacific Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
14.6.8.3.1. Arthritis
14.6.8.3.2. Dysplasia
14.6.8.3.3. Tendonitis
14.6.8.3.4. Inflammatory diseases
14.6.8.3.5. Immune Mediated Diseases
14.6.8.3.6. Bone and Spinal Cord Injuries
14.6.8.3.7. Others
14.6.8.4. Rest of Asia Pacific Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
14.6.8.4.1. Veterinary Hospitals
14.6.8.4.2. Veterinary Clinics
14.6.8.4.3. Veterinary Research Institutes
14.7. Key
Segment for Channeling Investments
14.7.1. By Country
14.7.2. By
Product Type
14.7.3. By
Treatment
14.7.4. By
Application
14.7.5. By End
User
15. Middle East and Africa Canine Stem Cell Therapy Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle
East and Africa Canine Stem Cell Therapy Market Revenue (US$ Mn)
15.2. Middle
East and Africa Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By Product Type
15.2.1. Embryonic
stem cells
15.2.2. Adult stem cells
15.3. Middle
East and Africa Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By Treatment
15.3.1. Intra-articular
15.3.2. Intra-lesion
15.3.3. Intra-venous
15.4. Middle
East and Africa Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By Application
15.4.1. Arthritis
15.4.2. Dysplasia
15.4.3. Tendonitis
15.4.4. Inflammatory
diseases
15.4.5. Immune
Mediated Diseases
15.4.6. Bone
and Spinal Cord Injuries
15.4.7. Others
15.5. Middle
East and Africa Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By End User
15.5.1. Veterinary
Hospitals
15.5.2. Veterinary
Clinics
15.5.3. Veterinary
Research Institutes
15.6. Middle
East and Africa Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Product Type
15.6.1.1.1. Embryonic stem cells
15.6.1.1.2. Adult stem cells
15.6.1.2. Saudi Arabia Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Treatment
15.6.1.2.1. Intra-articular
15.6.1.2.2. Intra-lesion
15.6.1.2.3. Intra-venous
15.6.1.3. Saudi Arabia Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.1.3.1. Arthritis
15.6.1.3.2. Dysplasia
15.6.1.3.3. Tendonitis
15.6.1.3.4. Inflammatory diseases
15.6.1.3.5. Immune Mediated Diseases
15.6.1.3.6. Bone and Spinal Cord Injuries
15.6.1.3.7. Others
15.6.1.4. Saudi Arabia Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.1.4.1. Veterinary Hospitals
15.6.1.4.2. Veterinary Clinics
15.6.1.4.3. Veterinary Research Institutes
15.6.2. UAE
15.6.2.1. UAE Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.2.1.1. Embryonic stem cells
15.6.2.1.2. Adult stem cells
15.6.2.2. UAE Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.2.2.1. Intra-articular
15.6.2.2.2. Intra-lesion
15.6.2.2.3. Intra-venous
15.6.2.3. UAE Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.2.3.1. Arthritis
15.6.2.3.2. Dysplasia
15.6.2.3.3. Tendonitis
15.6.2.3.4. Inflammatory diseases
15.6.2.3.5. Immune Mediated Diseases
15.6.2.3.6. Bone and Spinal Cord Injuries
15.6.2.3.7. Others
15.6.2.4. UAE Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.2.4.1. Veterinary Hospitals
15.6.2.4.2. Veterinary Clinics
15.6.2.4.3. Veterinary Research Institutes
15.6.3. Egypt
15.6.3.1. Egypt Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.3.1.1. Embryonic stem cells
15.6.3.1.2. Adult stem cells
15.6.3.2. Egypt Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.3.2.1. Intra-articular
15.6.3.2.2. Intra-lesion
15.6.3.2.3. Intra-venous
15.6.3.3. Egypt Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.3.3.1. Arthritis
15.6.3.3.2. Dysplasia
15.6.3.3.3. Tendonitis
15.6.3.3.4. Inflammatory diseases
15.6.3.3.5. Immune Mediated Diseases
15.6.3.3.6. Bone and Spinal Cord Injuries
15.6.3.3.7. Others
15.6.3.4. Egypt Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts,
By End User
15.6.3.4.1. Veterinary Hospitals
15.6.3.4.2. Veterinary Clinics
15.6.3.4.3. Veterinary Research Institutes
15.6.4. Kuwait
15.6.4.1. Kuwait Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
15.6.4.1.1. Embryonic stem cells
15.6.4.1.2. Adult stem cells
15.6.4.2. Kuwait Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
15.6.4.2.1. Intra-articular
15.6.4.2.2. Intra-lesion
15.6.4.2.3. Intra-venous
15.6.4.3. Kuwait Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.4.3.1. Arthritis
15.6.4.3.2. Dysplasia
15.6.4.3.3. Tendonitis
15.6.4.3.4. Inflammatory diseases
15.6.4.3.5. Immune Mediated Diseases
15.6.4.3.6. Bone and Spinal Cord Injuries
15.6.4.3.7. Others
15.6.4.4. Kuwait Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.4.4.1. Veterinary Hospitals
15.6.4.4.2. Veterinary Clinics
15.6.4.4.3. Veterinary Research Institutes
15.6.5. South
Africa
15.6.5.1. South Africa Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Product Type
15.6.5.1.1. Embryonic stem cells
15.6.5.1.2. Adult stem cells
15.6.5.2. South Africa Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Treatment
15.6.5.2.1. Intra-articular
15.6.5.2.2. Intra-lesion
15.6.5.2.3. Intra-venous
15.6.5.3. South Africa Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By Application
15.6.5.3.1. Arthritis
15.6.5.3.2. Dysplasia
15.6.5.3.3. Tendonitis
15.6.5.3.4. Inflammatory diseases
15.6.5.3.5. Immune Mediated Diseases
15.6.5.3.6. Bone and Spinal Cord Injuries
15.6.5.3.7. Others
15.6.5.4. South Africa Canine Stem Cell Therapy Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.5.4.1. Veterinary Hospitals
15.6.5.4.2. Veterinary Clinics
15.6.5.4.3. Veterinary Research Institutes
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Canine Stem Cell Therapy
Market Revenue (US$ Mn) and Forecasts, By Product Type
15.6.6.1.1. Embryonic stem cells
15.6.6.1.2. Adult stem cells
15.6.6.2. Rest of Middle East & Africa Canine Stem Cell Therapy
Market Revenue (US$ Mn) and Forecasts, By Treatment
15.6.6.2.1. Intra-articular
15.6.6.2.2. Intra-lesion
15.6.6.2.3. Intra-venous
15.6.6.3. Rest of Middle East & Africa Canine Stem Cell Therapy
Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Arthritis
15.6.6.3.2. Dysplasia
15.6.6.3.3. Tendonitis
15.6.6.3.4. Inflammatory diseases
15.6.6.3.5. Immune Mediated Diseases
15.6.6.3.6. Bone and Spinal Cord Injuries
15.6.6.3.7. Others
15.6.6.4. Rest of Middle East & Africa Canine Stem Cell Therapy
Market Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1. Veterinary Hospitals
15.6.6.4.2. Veterinary Clinics
15.6.6.4.3. Veterinary Research Institutes
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Product Type
15.7.3. By
Treatment
15.7.4. By
Application
15.7.5. By End
User
16. Latin America Canine Stem Cell Therapy Market Analysis and
Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin
America Canine Stem Cell Therapy Market Revenue (US$ Mn)
16.2. Latin
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Product Type
16.2.1. Embryonic
stem cells
16.2.2. Adult stem cells
16.3. Latin
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Treatment
16.3.1. Intra-articular
16.3.2. Intra-lesion
16.3.3. Intra-venous
16.4. Latin
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Application
16.4.1. Arthritis
16.4.2. Dysplasia
16.4.3. Tendonitis
16.4.4. Inflammatory
diseases
16.4.5. Immune
Mediated Diseases
16.4.6. Bone
and Spinal Cord Injuries
16.4.7. Others
16.5. Latin
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By End
User
16.5.1. Veterinary
Hospitals
16.5.2. Veterinary
Clinics
16.5.3. Veterinary
Research Institutes
16.6. Latin
America Canine Stem Cell Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1. Brazil Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.6.1.1.1. Embryonic stem cells
16.6.1.1.2. Adult stem cells
16.6.1.2. Brazil Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
16.6.1.2.1. Intra-articular
16.6.1.2.2. Intra-lesion
16.6.1.2.3. Intra-venous
16.6.1.3. Brazil Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.1.3.1. Arthritis
16.6.1.3.2. Dysplasia
16.6.1.3.3. Tendonitis
16.6.1.3.4. Inflammatory diseases
16.6.1.3.5. Immune Mediated Diseases
16.6.1.3.6. Bone and Spinal Cord Injuries
16.6.1.3.7. Others
16.6.1.4. Brazil Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.1.4.1. Veterinary Hospitals
16.6.1.4.2. Veterinary Clinics
16.6.1.4.3. Veterinary Research Institutes
16.6.2. Argentina
16.6.2.1. Argentina Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Product Type
16.6.2.1.1. Embryonic stem cells
16.6.2.1.2. Adult stem cells
16.6.2.2. Argentina Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Treatment
16.6.2.2.1. Intra-articular
16.6.2.2.2. Intra-lesion
16.6.2.2.3. Intra-venous
16.6.2.3. Argentina Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.3.1. Arthritis
16.6.2.3.2. Dysplasia
16.6.2.3.3. Tendonitis
16.6.2.3.4. Inflammatory diseases
16.6.2.3.5. Immune Mediated Diseases
16.6.2.3.6. Bone and Spinal Cord Injuries
16.6.2.3.7. Others
16.6.2.4. Argentina Canine Stem Cell Therapy Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.2.4.1. Veterinary Hospitals
16.6.2.4.2. Veterinary Clinics
16.6.2.4.3. Veterinary Research Institutes
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Product Type
16.6.3.1.1. Embryonic stem cells
16.6.3.1.2. Adult stem cells
16.6.3.2. Rest of Latin America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Treatment
16.6.3.2.1. Intra-articular
16.6.3.2.2. Intra-lesion
16.6.3.2.3. Intra-venous
16.6.3.3. Rest of Latin America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By Application
16.6.3.3.1. Arthritis
16.6.3.3.2. Dysplasia
16.6.3.3.3. Tendonitis
16.6.3.3.4. Inflammatory diseases
16.6.3.3.5. Immune Mediated Diseases
16.6.3.3.6. Bone and Spinal Cord Injuries
16.6.3.3.7. Others
16.6.3.4. Rest of Latin America Canine Stem Cell Therapy Market Revenue
(US$ Mn) and Forecasts, By End User
16.6.3.4.1. Veterinary Hospitals
16.6.3.4.2. Veterinary Clinics
16.6.3.4.3. Veterinary Research Institutes
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By Product
Type
16.7.3. By
Treatment
16.7.4. By
Application
16.7.5. By End
User
17. Competitive Benchmarking
17.1. Market
Share Analysis, 2021
17.2. Global
Presence and Growth Strategies
17.2.1. Mergers
and Acquisitions
17.2.2. Product
Launches
17.2.3. Investments
Trends
17.2.4. R&D
Initiatives
18. Player Profiles
18.1. Animacel
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key
Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. ANIMAL
CELL THERAPIES, INC
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Aratana
Therapeutics
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. Cell
Therapy Sciences
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Gallant
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. LiteCure,
LLC
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. Magellan
Stem Cells
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. Medrego
LLC
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. Stemcell
vet
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Vetbiologics
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key
Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. VetNetwork,
LLC
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. VETSTEM
BIOPHARMA
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. VetStem
Inc
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business Strategies
18.14. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
